HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Reply: Could weight loss contribute to the improved mobility with metformin in patients with myotonic dystrophy type 1?

AuthorsGuillaume Bassez, Etienne Audureau, Marc Peschanski
JournalBrain : a journal of neurology (Brain) Vol. 142 Issue 2 Pg. e6 (02 01 2019) ISSN: 1460-2156 [Electronic] England
PMID30615109 (Publication Type: Letter, Comment)
Chemical References
  • Metformin
Topics
  • Humans
  • Metformin
  • Myotonic Dystrophy
  • Weight Loss

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: